EPA and DHA Market Share, Growth Factors, Competitive Landscape, Mergers And Acquisitions
EPA and DHA Market Overview:
The EPA and DHA Market Share was valued at USD
1,670.04 Million in 2022. EPA and DHA market estimated to reach over USD
2,680.43 Million by 2030.and grow at a CAGR of 6.2% during the forecast period.
Growth drivers: Rising awareness of health benefits,
increasing prevalence of chronic diseases, growing demand for preventive
healthcare, and expanding applications in food, dietary supplements, and
clinical nutrition.
Key regions: North America, Europe, and Asia Pacific are
leading the market, with Asia Pacific expected to witness the fastest growth
due to rising disposable incomes and growing health awareness.
Market
Drivers:
Health benefits: EPA and DHA are associated with reducing the
risk of cardiovascular diseases, cognitive decline, and inflammatory
conditions.
Chronic disease prevalence: Rising cases of heart disease,
diabetes, and other chronic conditions are driving EPA and DHA market demand for
preventive measures, including EPA and DHA supplementation.
Preventive healthcare: Growing focus on proactive health
management is increasing the adoption of EPA and DHA for overall well-being.
Expanding applications: The use of EPA and DHA is expanding
beyond dietary supplements to include functional foods, infant formula, pet
food, and pharmaceuticals.
Market Key
Players:
KD Pharma
Group, Corbion NV, Novasep Holding SAS, Neptune Wellness Solutions, BASF SE,
Omega Protein Corporation, Croda International PLC, Novotech Nutraceuticals,
Polaris SA, and AlgalR NutraPharms Pvt. Ltd
Market
Segmentation:
The
Veterinary Diagnostic Imaging Market segmentation based on various factors,
including:
By Type: Eicosapentaenoic Acid (EPA) and
Docosahexaenoic Acid (DHA)
By Source: Fish Oil, Algae Oil, Krill Oil, and
Others
By Application: Infant Formula, Dietary Supplements,
Fortified Food and Beverages, Pharmaceuticals, and Others
Regional
Analysis
North
America: A Mature Market with Steady Growth
Dominant force: The North American region currently holds the
largest EPA and DHA market demand, driven by
factors like high disposable income, growing health awareness, and established
distribution channels.
Focus on preventive healthcare: Consumers are increasingly
opting for EPA and DHA supplements as part of their preventive healthcare
regimens, particularly for heart and brain health.
Key players: The market is dominated by established players
like BASF, DSM, and Amway, alongside regional players like Cargill and Omega
Nutrition.
Europe:
Stringent Regulations and Rising Demand
Regulatory landscape: Stringent regulations governing food
and dietary supplements in Europe present both challenges and opportunities for
market players.
Growing demand for fortified foods: Consumers are
increasingly seeking fortified food products enriched with EPA and DHA,
particularly for infant formula and functional foods.
Key players: Leading players include BASF, DSM, and Lonza,
with regional players like Aker BioMarine and Orkla Health also gaining
traction.
Asia
Pacific: A Booming Market with Diverse Drivers
Rapid economic growth: Rising disposable incomes and
increasing awareness of health benefits are fueling market expansion in this
region.
Focus on infant nutrition and brain development: The demand
for EPA and DHA-fortified infant formula is surging, driven by concerns about
child development.
Key players: International players like BASF and DSM are
present alongside regional players like China Resources and BYD Pharma.
Contact us:
Consegic Business intelligence Pvt
Ltd.
Contact no: (US) (505) 715-4344
Email: sales@consegicbusinessintelligence.com
Comments
Post a Comment